15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Travellers Vaccinated with Covishield ‘Should’ be Allowed into European Union – but Member States Have Final Say 30/06/2021 Kerry Cullinan Travellers who are fully vaccinated with vaccines authorised in the European Union (EU) “should” be allowed entry for non-essential travel – even if these vaccines were not “produced in facilities covered by the marketing authorisation in the EU”, a European Commission spokesperson for health, food safety and transport told Health Policy Watch on Wednesday. At […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> Posts navigation Newer posts
Travellers Vaccinated with Covishield ‘Should’ be Allowed into European Union – but Member States Have Final Say 30/06/2021 Kerry Cullinan Travellers who are fully vaccinated with vaccines authorised in the European Union (EU) “should” be allowed entry for non-essential travel – even if these vaccines were not “produced in facilities covered by the marketing authorisation in the EU”, a European Commission spokesperson for health, food safety and transport told Health Policy Watch on Wednesday. At […] Continue reading -> United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> Posts navigation Newer posts
United States Recommends ‘Pause’ In Johnson & Johnson COVID-19 Vaccine 13/04/2021 Raisa Santos The United States’ Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have recommended a “pause” in administration of Johnson & Johnson’s (J&J) single-dose COVID-19 vaccine out of an “abundance of caution” following six cases of a rare type of blood clotting among the 6.8 million US recipients of the […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> Posts navigation Newer posts
EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> Posts navigation Newer posts
European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> Posts navigation Newer posts